🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to compare XELOX +Bev +Tislelizumab with...
Status
Unknown
Location
Lin Yang
Start Date
2023-07-07
Trial ID
NCT05970302
Treatments Being Tested
A study to evaluate the efficacy and safety of tislelizumab combined with b...
Status
Unknown
Location
Sichuan Cancer Hospital
Start Date
2022-06-01
Trial ID
NCT05394233
Treatments Being Tested
To evaluate the clinical efficacy and safety of TAS-102 combined with bevac...
Status
Unknown
Location
FujianCH
Start Date
2022-04-01
Trial ID
NCT05314101
Treatments Being Tested
This study will look at whether adding daily oral zinc supplements to targe...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)
Start Date
2026-09-01
Trial ID
NCT07793695
This trial is designed to explore the efficacy and safety of interventional...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-02-19
Trial ID
NCT07157969
This is a Phase 1b/2 study to investigate the efficacy and safety of alcest...
Status
Active Not Recruiting
Location
Alaska Oncology and Hematology, Llc
Start Date
2023-01-29
Trial ID
NCT05609370
Treatments Being Tested
This is a prospective, randomized, open-label, multicenter phase II investi...
Status
Recruiting
Location
Ordensklinikum Linz GmbH
Start Date
2025-10-27
Trial ID
NCT06856837
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of transar...
Status
Completed
Location
Gao-Jun Teng
Start Date
2022-12-28
Trial ID
NCT05332496
Treatments Being Tested
Atezolizumab + Bevacizumab was superior to sorafenib in overall survival in...
Status
Recruiting
Location
Chinese PLA hospital
Start Date
2021-01-01
Trial ID
NCT06323382
Treatments Being Tested
This is a first-in-human, dose finding and dose expansion study to evaluate...
Status
Recruiting
Location
Usc Norris Comprehensive Cancer Center (Nccc)
Start Date
2024-04-12
Trial ID
NCT06233942
Treatments Being Tested